---
figid: PMC2898136__nihms-210716-f0003
figlink: /pmc/articles/PMC2898136/figure/F3/
number: F3
caption: Multiple cellular signalling pathways mediate the effects of prostaglandin
  E2 (PGE2) and leukotriene B4 (LTB4) on the regulation of epithelial tumour cell
  proliferation, survival, and migration and invasion. PGE2 stimulates cell proliferation
  through multiple cascades in both colorectal cancer (CRC) and non-small-cell lung
  cancer cells. PGE2 also induces cell proliferation through a glycogen synthase kinase-3β
  (GSK3β)–β-catenin (β-cat) pathway in CRC cells or by the upregulation of aromatase
  in breast cancer cells. PGE2 inhibition of GSK3β reduces β-catenin phosphorylation
  and thereby prevents its degradation, leading to accumulation, nuclear translocation
  and functional activity of β-catenin. PGE2 promotes CRC cell survival by activating
  a PI3K–Akt– peroxisome proliferator-activated receptor-δ (PPARδ) cascade in vitro
  and in vivo. In addition, PGE2 induces CRC cell migration and invasion through β-arrestin-1–SRC–epidermal
  growth factor receptor (EGFR)–PI3K–Akt signalling in vitro and in vivo. PGE2 transactivation
  of EGFR also depends on the extracellular release of an EGF-like ligand in CRC cell
  lines and a normal gastric epithelial cell line. PGE2 also induces cell migration
  and invasion through an Erk–ETS1–matrix metalloproteinase 2 (MMP2) cascade in pancreatic
  cancer cell lines or through the upregulation of C-C chemokine receptor 7 (CCR7)
  in breast cancer cell lines. LTB4 stimulates cell proliferation and promotes cell
  survival through a BLT1–Erk pathway in CRC cell lines or through both Mek–Erk and
  PI3K–Akt pathways in human pancreatic cancer cell lines. P, phosphorylation.
pmcid: PMC2898136
papertitle: Eicosanoids and cancer.
reftext: Dingzhi Wang, et al. Nat Rev Cancer. ;10(3):181-193.
pmc_ranked_result_index: '31309'
pathway_score: 0.9708354
filename: nihms-210716-f0003.jpg
figtitle: Eicosanoids and cancer
year: ''
organisms: Homo sapiens
ndex: 8949d787-dec6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2898136__nihms-210716-f0003.html
  '@type': Dataset
  description: Multiple cellular signalling pathways mediate the effects of prostaglandin
    E2 (PGE2) and leukotriene B4 (LTB4) on the regulation of epithelial tumour cell
    proliferation, survival, and migration and invasion. PGE2 stimulates cell proliferation
    through multiple cascades in both colorectal cancer (CRC) and non-small-cell lung
    cancer cells. PGE2 also induces cell proliferation through a glycogen synthase
    kinase-3β (GSK3β)–β-catenin (β-cat) pathway in CRC cells or by the upregulation
    of aromatase in breast cancer cells. PGE2 inhibition of GSK3β reduces β-catenin
    phosphorylation and thereby prevents its degradation, leading to accumulation,
    nuclear translocation and functional activity of β-catenin. PGE2 promotes CRC
    cell survival by activating a PI3K–Akt– peroxisome proliferator-activated receptor-δ
    (PPARδ) cascade in vitro and in vivo. In addition, PGE2 induces CRC cell migration
    and invasion through β-arrestin-1–SRC–epidermal growth factor receptor (EGFR)–PI3K–Akt
    signalling in vitro and in vivo. PGE2 transactivation of EGFR also depends on
    the extracellular release of an EGF-like ligand in CRC cell lines and a normal
    gastric epithelial cell line. PGE2 also induces cell migration and invasion through
    an Erk–ETS1–matrix metalloproteinase 2 (MMP2) cascade in pancreatic cancer cell
    lines or through the upregulation of C-C chemokine receptor 7 (CCR7) in breast
    cancer cell lines. LTB4 stimulates cell proliferation and promotes cell survival
    through a BLT1–Erk pathway in CRC cell lines or through both Mek–Erk and PI3K–Akt
    pathways in human pancreatic cancer cell lines. P, phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - PIK3R5
  - EGFR
  - CCR7
  - SRC
  - MAP2K2
  - MMP2
  - PIK3R6
  - MAP2K1
  - PIK3CD
  - PIK3R3
  - CYP19A1
  - PIK3CB
  - AKT1
  - PIK3CG
  - AKT3
  - AKT2
  - MAPK3
  - ARAF
  - KRAS
  - PIK3CA
  - HRAS
  - GSK3B
  - NRAS
  - PIK3R4
  - BRAF
  - RAF1
  - PGE
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: CCR7
  symbol: CCR7
  source: hgnc_symbol
  hgnc_symbol: CCR7
  entrez: '1236'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MMP2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
chemicals:
- word: PGE
  source: MESH
  identifier: D011458
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2898136__F3
redirect_from: /figures/PMC2898136__F3
figtype: Figure
---
